世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い



世界の動物医療市場 2018-2022年

Global Animal Healthcare Market 2018-2022

 

出版社 出版日電子媒体価格ページ数
TechNavio
テクナビオ
2018年2月 US$ 2,500
シングルユーザライセンス
118p

サマリー

このレポートは世界の動物医療市場を調査したTechNavioの調査報告書です。

Report Details

About Animal Healthcare
Animal healthcare involves guarding, preserving, and preventing disease in and providing necessary veterinary services to animals to enhance their quality of life, increase their lifespan, and increase the yield of animal foods.

Technavio’s analysts forecast the global animal healthcare market is expected to grow to USD 32.04 billion during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global animal healthcare market for 2018-2022. To calculate the market size, the report considers the revenue generated from the retail sales of products which includes pharmaceutical, feed additive, and biological in the Americas, EMEA, and APAC.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Animal Healthcare Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Bayer 91
- Boehringer Ingelheim 95
- Eli Lilly 100
- Merck 105
- Zoetis


Market driver
- Increase in animal ownership
- For a full, detailed list, view our report

Market challenge
- Contamination of animal source foods
- For a full, detailed list, view our report

Market trend
- Growing animal healthcare awareness
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?


You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.





目次

Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
- Segmentation by product
- Comparison by product
- Pharmaceutical
- Feed additive
- Biologicals
- Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas
- EMEA
- APAC
- Key leading countries
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Growing animal healthcare awareness
- Increasing M&A activity
- Increase in consumer preference towards protein-rich food
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Bayer
- Boehringer Ingelheim
- Eli Lilly
- Merck
- Zoetis
- Other prominent vendors
- List of abbreviations
List of Exhibits
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global - Market size and forecast 2017-2022 ($ bn)
Exhibit 08: Global - Year over year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Product - Market share 2017-2022 (%)
Exhibit 18: Comparison by product
Exhibit 19: Pharmaceutical - Market size and forecast 2017-2022 ($ bn)
Exhibit 20: Pharmaceutical - Year over year growth 2018-2022 (%)
Exhibit 21: Feed additive - Market size and forecast 2017-2022 ($ bn)
Exhibit 22: Feed additive - Year over year growth 2018-2022 (%)
Exhibit 23: Biologicals- Market size and forecast 2017-2022 ($ bn)
Exhibit 24: Biologicals? Year over year growth 2018-2022 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global - Market share by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Americas - Market size and forecast 2017-2022 ($ bn)
Exhibit 30: Americas - Year over year growth 2018-2022 (%)
Exhibit 31: EMEA - Market size and forecast 2017-2022 ($ bn)
Exhibit 32: EMEA - Year over year growth 2018-2022 (%)
Exhibit 33: APAC - Market size and forecast 2017-2022 ($ bn)
Exhibit 34: APAC - Year over year growth 2018-2022 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Diseases caused by animals and their mode of transmission to humans
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Vendor overview
Exhibit 44: Bayer - Business segments
Exhibit 45: Bayer - Organizational developments
Exhibit 46: Bayer - Geographic focus
Exhibit 47: Bayer - Segment focus
Exhibit 48: Bayer - Key offerings
Exhibit 49: Vendor overview
Exhibit 50: Boehringer Ingelheim - Business segments
Exhibit 51: Boehringer Ingelheim - Organizational developments
Exhibit 52: Boehringer Ingelheim - Geographic focus
Exhibit 53: Boehringer Ingelheim - Segment focus
Exhibit 54: Boehringer Ingelheim - Key offerings
Exhibit 55: Vendor overview
Exhibit 56: Eli Lilly - Business segments
Exhibit 57: Eli Lilly - Organizational developments
Exhibit 58: Eli Lilly - Geographic focus
Exhibit 59: Eli Lilly - Segment focus
Exhibit 60: Eli Lilly - Key offerings
Exhibit 61: Vendor overview
Exhibit 62: Merck - Business segments
Exhibit 63: Merck - Organizational developments
Exhibit 64: Merck - Geographic focus
Exhibit 65: Merck - Segment focus
Exhibit 66: Merck - Key offerings
Exhibit 67: Vendor overview
Exhibit 68: Zoetis - Business segments
Exhibit 69: Zoetis - Organizational developments
Exhibit 70: Zoetis - Geographic focus
Exhibit 71: Zoetis - Segment focus
Exhibit 72: Zoetis - Key offerings

 

COPYRIGHT(C) 2011-2019 DATA RESOURCES, Inc. ALL RIGHTS RESERVED.